Pages that link to "Q46794018"
Jump to navigation
Jump to search
The following pages link to Amiloride restores renal medullary osmolytes in lithium-induced nephrogenic diabetes insipidus (Q46794018):
Displaying 23 items.
- Molecular mechanisms of urea transport in health and disease (Q26865708) (← links)
- Lithium Accumulates in Neurogenic Brain Regions as Revealed by High Resolution Ion Imaging (Q28816923) (← links)
- Expression of transporters involved in urine concentration recovers differently after cessation of lithium treatment (Q33727794) (← links)
- αENaC-Mediated Lithium Absorption Promotes Nephrogenic Diabetes Insipidus (Q33738668) (← links)
- Urea transport in the kidney (Q34348742) (← links)
- Lithium nephrotoxicity revisited (Q34658401) (← links)
- Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus. (Q35602671) (← links)
- Lithium nephrotoxicity (Q35686024) (← links)
- Mass spectrometric imaging of metabolites in kidney tissues from rats treated with furosemide (Q35951938) (← links)
- Attenuation of lithium-induced natriuresis and kaliuresis in P2Y₂ receptor knockout mice (Q36132548) (← links)
- Chronic use of chloroquine disrupts the urine concentration mechanism by lowering cAMP levels in the inner medulla (Q36309457) (← links)
- Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment. (Q36724058) (← links)
- Lithium: a versatile tool for understanding renal physiology. (Q36836247) (← links)
- Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride (Q36843452) (← links)
- Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus (Q37052068) (← links)
- Molecular mechanisms in lithium-associated renal disease: a systematic review (Q38847068) (← links)
- Prasugrel suppresses development of lithium-induced nephrogenic diabetes insipidus in mice (Q38944892) (← links)
- Amiloride blocks lithium entry through the sodium channel thereby attenuating the resultant nephrogenic diabetes insipidus. (Q39860982) (← links)
- Metabolic profiling of kidney and urine in rats with lithium-induced nephrogenic diabetes insipidus by (1)H-NMR-based metabonomics (Q43239277) (← links)
- Hydrochlorothiazide attenuates lithium-induced nephrogenic diabetes insipidus independently of the sodium-chloride cotransporter. (Q45889624) (← links)
- Genetic Deletion of P2Y Receptor Offers Long-Term (5 Months) Protection Against Lithium-Induced Polyuria, Natriuresis, Kaliuresis, and Collecting Duct Remodeling and Cell Proliferation (Q60951316) (← links)
- Nephrogenic Diabetes Insipidus (Q90540541) (← links)
- Nrf2 activation protects against lithium-induced nephrogenic diabetes insipidus (Q92668499) (← links)